California Marijuana

TORONTO –   MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”) a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce that Harvest Medicine’s study entitled, “Self-Reported Effects of Illness Severity, Depression and Anxiety in Fibromyalgia Patients: A Large Retrospective Case Series” has been published in the peer-reviewed American Journal of Endocannabinoid Medicine. Harvest Medicine Inc. (“Harvest Medicine” or “HMED”) includes a medical clinic network, and is a wholly owned subsidiary of MediPharm Labs. The retrospective study was led by HMED and reviewed data from 805 patients who indicated fibromyalgia as a primary reason for seeking medical cannabis and had a minimum of one follow-up assessment. The majority of patients (76.1%) reported using CBD oil, which aligns with the current practice guidelines for authorizing medical cannabis as an adjuvant therapy for managing chronic pain. T

Profitability is a key indicator of a dispensary’s success, but a recent industry survey found only about 60 percent of cannabis operators are profitable. Providing reliable products and services at good prices is only part of the profitability puzzle. Employing the best people and establishing a healthy marketing plan are two more. Arguably, the most complicated part is creating that nebulous intangible known as “community.” How does a dispensary attack all those objectives while remaining compliant with relevant laws and regulations and keeping an eye on the bottom line? Fortunately, automation can help even the smallest operator, and automated tools become more sophisticated by the year. Here are the top 4 tools every dispensary needs in order to run a successful business. 1. Data and analytics Day-to-day operations involve thousands of data points, each representing a crucial piece of information about a dispensary’s performance. Finding a way to represent that data clearly is

WASHINGTON – The U.S. Department of Health and Human Services (HHS) has recommended reclassifying cannabis from Schedule I to a less restrictive Schedule III under the Controlled Substances Act, following President Biden’s request last year for the Department of Justice (DOJ) and HHS to “expeditiously” reconsider the plant’s classification. In a letter dated Aug. 29, HHS Assistant Secretary for Health Rachel Levine submitted the department’s rescheduling recommendation to Drug Enforcement Administration (DEA) Administrator Anne Milgram, according to Bloomberg News . A DEA spokesperson confirmed the department received the letter and will initiate a review. After the review is complete, the nation’s top drug enforcement agency will forward its recommendation to U.S. Attorney General Merrick Garland for action. On Wednesday, White House Press Secretary Karine Jean-Pierre said the DOJ and HHS were working through an independent process guided by evidence. “We’re going to let that pro

No matter how you pour it, beverage revenue across alcoholic drinks, non-alcoholic drinks, hot drinks, and cannabis-infused drinks has been growing each year since 2020. But no drink category comes close to the opportunity presented by the cannabis-infused segment, with an estimated compound annual growth rate of approximately 50 percent over the next five years. Industry brands like Tilray are betting big on the adult beverage category with a recent $85-million Anheuser-Busch deal that triples its beverage portfolio through the acquisition of eight new brands—a massive distribution advantage should federal legalization take hold. But according to data from cannabis analytics firm BDSA, it’s brands like Uncle Arnie’s , Levia , and Keef Cola that have been the most popular infused drink options for American palates and wallets. BDSA’s recent market research on the opportunities in the cannabis beverage market provides an informative look into the growth of the segment, going beyon

East Brunswick, NJ — When Mastercard ordered a halt on all cannabis transactions involving its debit card purchases, it rocked the industry—and its impact continues as retailers scramble for solutions on how to compliantly process cashless payments at an affordable price. With fears that other financial institutions might follow suit, Zenco Payments, a technology hub built by banking industry experts for the cannabis payment ecosystem, offers compliant payment options for businesses to help them remain cashless in a regulatory complaint manner during this tumultuous time. Zenco has built a closed-end loop payment solution that allows consumers to use their cellphone to process the ACH payment thus passing the use of debit cards completely. One of the fastest growing cashless payment solutions nationally, Zenco offers: Zenco Mobile Pay: An easy-to-use app that allows consumers to purchase cannabis without cash, leading to increased sales and a better customer shopping experience. Z

With only six licensed medical dispensaries, Washington D.C. is not typically regarded as a cannabis destination. But when you combine the ability to easily self-certify for the district’s medical program with 20.7 million domestic visitors who spent $8.1 billion in 2022, you can understand why it should be up there with places like Denver and Las Vegas . While the law in D.C. reads medical-only sales with adult use decriminalized, the fine print allows for enough finessing that adults 21 and over can essentially walk into a dispensary and purchase cannabis with or without a doctor’s recommendation. The U.S. capital also has reciprocity for individuals with a valid patient registration issued by one of 38 U.S. states and territories. The non-D.C. resident medical cannabis patient registration process is incredibly simple for domestic and international visitors who are at least 21 years old. However, it does require $30 and a small amount of consumer initiative, which can be off-put

GOLDEN, Colo. — MC Nutraceuticals and Kush.com announced today that the two companies have entered into a strategic partnership. The union will amplify their shared value proposition throughout the Kush.com platform and pass along special MC Nutraceuticals promotions to Kush.com’s current members. The agreement brings together Kush.com’s premier cannabinoid marketplace and MC Nutraceuticals’ industry-leading catalog of 42 cannabinoids and counting. Starting this week, MC Nutraceuticals will feature its new Kush.com Certified Bulk Cannabinoids, best-in-class service offerings like custom cannabinoid blends, and high-value promotions throughout the Kush.com ecosystem. “We are excited to launch our new Enterprise program with our long-term partner, MC Nutraceuticals. Considering all the headwinds facing our industry; we believe that collaboration with the right partners is the best path forward” – John Lynch, Kush.com CEO Kush.com members can expect new cannabinoid offerings like THCA

VANCOUVER, BC, and TORONTO – BZAM Ltd. (the “Company” or “BZAM”) (CSE: BZAM) (US-OTC: BZAMF), a leading Canadian cannabis producer, is pleased to announce its financial and operating results for the three and six months ended June 30, 2023 (“Q2 2023”). These filings are available for review on the Company’s SEDAR+ profile at www.sedarplus.ca. All financial information is provided in Canadian dollars except where otherwise indicated. Q2 2023 Highlights: Achieved quarterly gross revenues of $30.0 million during Q2 2023, up 89% from Q2 2022; Achieved quarterly net revenues of $19.3 million for Q2 2023, up 66% from Q2 2022; According to Hifyre, the Company captured market share of 4.4% in Q2 2023, ranking as the 7th largest producer in Canada; Executed on our post-merger plan to right-size our production platform, monetize redundant facilities, and reduce our cost base. This includes the sale of the Midway, BC facility (completed August 4, 2023) and the Maple Ridge, BC facility (expe

PHOENIX, Ariz. — To Raymond Navis, there’s no such thing as “business as usual” when it comes to executive recruitment and networking in the cannabis sector. One of the leading headhunters in the cannabis industry, he is responsible for placing some of the top positions in the sector as well as connecting the who’s who of the industry at exclusive networking events. In a post-pandemic business world where our networks have shrunk by as much as 16%, according to recent statistics, Raymond Navis is changing the way companies recruit top level talent and make business connections that matter. Before his entrance into cannabis, Navis spent decades building his expertise in the banking industry and he founded R.W. Navis and Associates to offer cannabis businesses a more sophisticated approach to executive recruiting. This has proven to be transformative in matching top candidates with outstanding opportunities. His relationship to key management has also led to capital raise assignments f

We’re about a year into what is undoubtedly the most challenging stretch the cannabis industry has faced since the legalization movement began. The initial hype surrounding the industry’s potential as the next great American boom has slid back to a harsh reality. The combination of local government blunders and federal government inaction , crippling levels of taxation, and an illicit market that largely operates with impunity has mired legal operators with challenges. As a result, businesses are operating in a drastically different climate from the one that attracted so many to the industry. And different climates call for a different way of doing business. We should be asking ourselves, can we operate sustainable, profitable companies during challenging market dynamics ? Are we able to switch our mindset from growth at all costs to survival at any price? These are the moments when the mettle of the entrepreneurs and executives in the space is put to the test. We’ve assembled

MINNEAPOLIS — Boveda, the global leader in 2-way humidity control, has once again been honored with the prestigious title of Best Places to Work 2023 by the Minneapolis/St. Paul Business Journal. This marks the fifth consecutive year that Boveda has received this recognition in the medium-sized category, which includes businesses with 50 to 99 employees in Minnesota. This year marks the 25th year of the Best Places to Work awards hosted by The Minneapolis/St. Paul Business Journal and research partner, Omaha, Nebraska-based Quantum Workplace. To be considered eligible, a current employee must enter the business for nomination. 70 companies across the region were identified and scored top marks on a confidential employee survey that evaluated leadership, company culture, pain points, and overall job satisfaction. “We are thrilled to be recognized as a Best Places to Work five years in a row because it’s based on the dedication, passion and commitment of an incredibly talented team,”

NEW LONDON, N.H. — Orange Photonics, a pioneer in revolutionizing HPLC technology, is proud to announce that the US Food and Drug Administration (FDA) has selected the LightLab 3 High Sensitivity (HS) Cannabis Analyzer to play a pivotal role in its efforts to regulate the national cannabis industry. This move comes after numerous international and state regulatory agencies have successfully implemented LightLab 3 HS to support consumer safety and business licensure. The FDA’s decision to deploy LightLab 3 HS Cannabis Analyzer stems from its commitment to address consumer safety concerns associated with food-related products containing CBD and Delta-8 THC. Over the past six years, the FDA has issued numerous consumer safety notices and letters to companies manufacturing or marketing CBD, and more recently, Delta-8 products that fail to comply with various FDA regulations. In addition, the FDA will potentially play a key role intercepting international and intrastate illicit shipments.

MEDFORD, Ore. –   Grown Rogue International Inc. (“Grown Rogue” or the “Company”) (CSE: GRIN) (OTC: GRUSF), a craft cannabis company operating in Oregon and Michigan, announces that, further to its news releases on July 4, 2023 and July 13, 2023, it has closed the second and final tranche of a non-brokered private placement of unsecured convertible debentures (each, a “Debenture”) for gross proceeds of US$1,000,000, for a total aggregate principal amount under both tranches (the “Principal Amount”) of US$6,000,000 (the “Offering”). Additionally, on closing, the Company issued to subscribers under the second tranche of the Offering (each a “Debentureholder”) an aggregate of 2,816,250 common share purchase warrants (the “Warrants”), representing one-half of one warrant for each C$0.24 of Principal Amount subscribed. The Debentures will mature four years from the Closing Date (the “Maturity Date”), bear interest at a rate equal to 9% per annum, payable in United States currency on the l

LAVAL, Quebec – Neptune Wellness Solutions Inc. (“Neptune” or the “Company”) (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced its financial and operating results for the three-month period ending June 30, 2023. During the first quarter of 2024 Neptune continued to focus on operational improvements, cost reductions and operational efficiencies.  In the first quarter the Company’s organic baby food product line, Sprout, performed well with 26% gross profit margins achieved, ahead of Neptune’s projection of 22% in 2024. Neptune continues to prioritize cost management and the implementation of measures to increase operational efficiency throughout the business and the Company expects to see this in further cost savings through fiscal 2024. First Quarter 2024 Financial Highlights: Consolidated net revenue of $10.6 million, down from $16.3 million for the same period last year. This is largely due t